Navigation Links
New Anti-Rejection Medication 6-Month Results for Heart Transplant,Recipients to Be Released at International Heart and Lung,Transplant Meeting

ADDISON, Texas, April 19, 2007 /PRNewswire/ -- New clinical trial results for heart transplant patients will be released at the upcoming International Society for Heart and Lung Transplantation (ISHLT) 27th Annual Meeting and Scientific Sessions at the Hilton San Francisco, April 25-28, 2007. Results show promise for efficacy and safety of immunosuppression therapy and lower incidences of acute organ rejection in heart transplants.

    Research to be presented includes:

    --  Six Month Data on Cyclosporine Reduction and Impact on Renal Function

        with Everolimus In De Novo Heart Transplant Recipients will be

        presented Wednesday, April 25 during a luncheon symposium at 12:30pm

        PDT.

    --  6 Month Data from a 12 Month Study of Everolimus with Reduced

        Cyclosporine Exposure vs. MMF and Conventional Cyclosporine in De Novo

        Heart Transplant Recipients will be presented during the same luncheon

        symposium on April 25.

The leading cause of death during the first year following heart transplant is acute rejection of the transplanted organ. The patient's immune system attacks the heart as if it were a foreign object until it no longer functions properly. The one-year survival rate after transplantation is approximately 80 percent; this number drops to nearly 50 percent after 10 years.

About ISHLT

The International Society for Heart and Lung Transplantation (ISHLT) is a not-for-profit organization dedicated to the advancement of the science and treatment of end-stage heart and lung diseases. Created in 1981, the Society now includes more than 2,200 members from 45-plus countries, representing a variety of disciplines involved in the management and treatment of end-stage heart and lung disease.

ISHLT manages two vital databases. The International Heart and Lung Registry is a one-of-a-kind registry that has been collecting data since 1983 from 223 hospitals from 18 countries. The ISHLT Mechanical Circulatory Device (MCSD) database has been collecting data since 2002 with the aim of identifying patient populations who may benefit from MCSD implantation, generating predictive models for outcomes; and assessing the mechanical and biological reliability of current and future devices. In Fall 2006, ISHLT released the first international guidelines for heart failure patient management. For more information, visit http://www.ishlt.org.

Contact: Lauren Mason

              (210) 731-6646

              


lmason@masonpr.com

CONTACT: Lauren Mason, +1-210-731-6646, , forInternational Society for Heart and Lung Transplantation lmason@masonpr.com

Web site: http://www.ishlt.org/

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Related medicine technology :

1. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
2. Shire Announces Positive Results of Studies With Guanfacine Extended Release, An Investigational Nonstimulant Medication Filed for the Treatment of ADHD in Children and Adolescents
3. New Data Focuses on Abuse of Stimulant Medication
4. Separate Sets of Research Show Treatment Improved Quality of Life in as Early as Three Weeks; Patient Adherence to Medication is Multifactorial
5. FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications
6. Survey: Migraine Patients Taking Potentially Addictive Barbiturate or Opioid Medications Not Approved by FDA as Migraine Treatments
7. Drug for Treatment of Heart Failure Does Not Improve Survival, Compared to More Widely-used Medication
8. Study Sheds Light on Medication Treatment Options for Bipolar Disorder
9. Stanford Study Finds No Conclusive Benefit From Treating Kleptomania With Medication
10. Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
11. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... NEW YORK , May 23, 2016 /PRNewswire/ ... Mass Spectrometry Market Size, Share, Development, Growth and ... Platform (Hybrid, Single and Other), by Application (Drug ... Others), by End Users (Pharmaceuticals, Life Science and ... Published by P&S Market Research, the global ...
(Date:5/23/2016)... The World Health Organization (WHO) expanded the Intended Use of ... 13 years, and above. Effective immediately, the PrePex device, manufactured ... males in the 14 priority countries in Southern and ... circumcision device to receive WHO Prequalification on 31 May 2013. ... " The expanded use of PrePex for younger ...
(Date:5/23/2016)... 2016 Experts from various countries ... and the role of technology in innovative healthcare ... The First International Conference of VPS-Penn Medicine opened in ... presence of Sheikh Nahyan bin Mubarak Al Nahyan, Minister of ... which helps provide personalized medicine and tailor-made healthcare in disease ...
Breaking Medicine Technology:
(Date:5/25/2016)... ... 25, 2016 , ... Today American University of Antigua (AUA) ... announced the AUA-FIU Global MD Program. Students in the Global MD Program ... a Certificate of Completion from the FIU Herbert Wertheim College of Medicine Clinical ...
(Date:5/25/2016)... ... ... Today Omega Institute, a leading destination for yoga education in New York’s Hudson ... the growing field of yoga therapy . Yoga therapy adapts the practice of ... injuries, illnesses, and temporary or chronic health conditions. , “Yoga therapy is a complementary ...
(Date:5/25/2016)... ... May 25, 2016 , ... The Global Wellness Summit (GWS) today announced ... wellness offerings of Europe, a continent that pioneered the medical/wellness concept for the world. ... pioneers in medical wellness, including Henri Chenot, Founder of the Chenot Group, which operates ...
(Date:5/25/2016)... ... May 25, 2016 , ... Conrad Siegel Actuaries, delivering comprehensive ... Prescription Drug survey , an employee benefits survey measuring how Central ... December 2015, indicates that employers are turning to consumer directed health care and ...
(Date:5/25/2016)... ... May 25, 2016 , ... Laser Skin & ... turn back the hands of time of female aging. The Juliet™ ... Women with symptoms such as leakage, laxity, itchiness and pain have reported real relief ...
Breaking Medicine News(10 mins):